دورية أكاديمية

Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene

التفاصيل البيبلوغرافية
العنوان: Exacerbated Renal and Hematologic Toxicities to Ifosfamide and Doxorubicin-Based Chemotherapy in a Patient with Retroperitoneal Liposarcoma Harboring a Germline Mutation in the WRN Gene
المؤلفون: Awni, Beatriz Mendes, Holanda Lopes, Carlos Diego, Harada, Guilherme, Salgues, Alessandra Corte Real, França, Gilmar de Andrade, Testagrossa, Leonardo de Abreu, Queiroz, Marcelo Araujo, Gonçalves e Silva, Adriano, Ferreira, Fabio de Oliveira, Munhoz, Rodrigo Ramella
المصدر: Case Reports in Oncology ; volume 15, issue 1, page 170-175 ; ISSN 1662-6575
بيانات النشر: S. Karger AG
سنة النشر: 2022
مصطلحات موضوعية: Oncology
الوصف: Werner’s syndrome is caused by the inactivation of both WRN alleles and is characterized by premature aging and increased risk of neoplasms, especially those of mesenchymal origins, such as sarcomas. Given the characteristic genomic instability, patients with this syndrome are more susceptible to develop toxicities when exposed to cytotoxic agents, such as alkylators and anthracyclines. The impact of the monoallelic WRN mutation on treatment-associated toxicities is poorly understood. Here, we report a patient with locally advanced dedifferentiated liposarcoma of the retroperitoneum harboring a heterozygous germline inactivation mutation in the WRN gene, who was treated with a classic regimen of ifosfamide and doxorubicin and developed exacerbated and prolonged hematological and renal toxicities.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1159/000521624
الإتاحة: https://doi.org/10.1159/000521624Test
https://www.karger.com/Article/Pdf/521624Test
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test/ ; https://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.C26806F2
قاعدة البيانات: BASE